|

Asthma Clinical Trials in New York

29 recruiting studies across 1 city

Browse by City

New York
29 trials

All Trials in New York

Phase
Trial Phase Dist.
Individualizing Treatment for Asthma in Primary Care (Full Study)Phase 4<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3<1 mi
Allergy and Immunology Natural History Study—<1 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaPhase 2<1 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)—<1 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaPhase 2<1 mi
Biologics And Clinical Immunology Cohort at Sinai—<1 mi
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaPhase 4<1 mi
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaPhase 2<1 mi
NIOSH R21 WTC Asthma—<1 mi
Protocol CAUSE-03 / CHEETAH—<1 mi
Patient Reported Outcomes for Acute Asthma Care Treatment—<1 mi
Asthma Symptom Perception StudyN/A<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 34 mi
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaPhase 44 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 25 mi
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaN/A5 mi
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsPhase 36 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)Phase 312 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentPhase 312 mi
Investigating Dupilumab's Effect in Asthma by GenotypePhase 412 mi
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)Phase 212 mi
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPhase 312 mi
ASTHMAXcel Voice StudyN/A12 mi
AeviceMD for Detection of Wheeze in Pediatric and Adult Populations—12 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 313 mi
A Study to Evaluate Solriktug in Adult Participants With AsthmaPhase 214 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 225 mi
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Phase 329 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.